Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1

PERK signaling is required for cancer invasion and there is interest in targeting this pathway for therapy. Unfortunately, chemical inhibitors of PERK's kinase activity cause on-target side effects that have precluded their further development. One strategy for resolving this difficulty would b...

Full description

Bibliographic Details
Main Authors: Feng, Yu-Xiong, Reinhardt, Ferenc, Jin, Dexter X., Sokol, Ethan Samuel, Miller, Daniel Handel, Gupta, Piyush
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Published: Nature Publishing Group 2018
Online Access:http://hdl.handle.net/1721.1/114663
https://orcid.org/0000-0003-1533-6730
https://orcid.org/0000-0002-2988-0537
https://orcid.org/0000-0002-4866-1145
https://orcid.org/0000-0002-9703-1780
_version_ 1826189275280965632
author Feng, Yu-Xiong
Reinhardt, Ferenc
Jin, Dexter X.
Sokol, Ethan Samuel
Miller, Daniel Handel
Gupta, Piyush
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Feng, Yu-Xiong
Reinhardt, Ferenc
Jin, Dexter X.
Sokol, Ethan Samuel
Miller, Daniel Handel
Gupta, Piyush
author_sort Feng, Yu-Xiong
collection MIT
description PERK signaling is required for cancer invasion and there is interest in targeting this pathway for therapy. Unfortunately, chemical inhibitors of PERK's kinase activity cause on-target side effects that have precluded their further development. One strategy for resolving this difficulty would be to target downstream components of the pathway that specifically mediate PERK's pro-invasive and metastatic functions. Here we identify the transcription factor CREB3L1 as an essential mediator of PERK's pro-metastatic functions in breast cancer. CREB3L1 acts downstream of PERK, specifically in the mesenchymal subtype of triple-negative tumors, and its inhibition by genetic or pharmacological methods suppresses cancer cell invasion and metastasis. In patients with this tumor subtype, CREB3L1 expression is predictive of distant metastasis. These findings establish CREB3L1 as a key downstream mediator of PERK-driven metastasis and a druggable target for breast cancer therapy.
first_indexed 2024-09-23T08:12:13Z
format Article
id mit-1721.1/114663
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T08:12:13Z
publishDate 2018
publisher Nature Publishing Group
record_format dspace
spelling mit-1721.1/1146632022-09-30T08:18:31Z Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1 Feng, Yu-Xiong Reinhardt, Ferenc Jin, Dexter X. Sokol, Ethan Samuel Miller, Daniel Handel Gupta, Piyush Massachusetts Institute of Technology. Department of Biology Koch Institute for Integrative Cancer Research at MIT Jin, Dexter X. Sokol, Ethan Samuel Miller, Daniel Handel Gupta, Piyush PERK signaling is required for cancer invasion and there is interest in targeting this pathway for therapy. Unfortunately, chemical inhibitors of PERK's kinase activity cause on-target side effects that have precluded their further development. One strategy for resolving this difficulty would be to target downstream components of the pathway that specifically mediate PERK's pro-invasive and metastatic functions. Here we identify the transcription factor CREB3L1 as an essential mediator of PERK's pro-metastatic functions in breast cancer. CREB3L1 acts downstream of PERK, specifically in the mesenchymal subtype of triple-negative tumors, and its inhibition by genetic or pharmacological methods suppresses cancer cell invasion and metastasis. In patients with this tumor subtype, CREB3L1 expression is predictive of distant metastasis. These findings establish CREB3L1 as a key downstream mediator of PERK-driven metastasis and a druggable target for breast cancer therapy. National Science Foundation (U.S.) (Grant 1122374) 2018-04-12T14:33:14Z 2018-04-12T14:33:14Z 2017-10 2016-12 2018-04-09T21:59:42Z Article http://purl.org/eprint/type/JournalArticle 2041-1723 http://hdl.handle.net/1721.1/114663 Feng, Yu-Xiong et al. “Cancer-Specific PERK Signaling Drives Invasion and Metastasis through CREB3L1.” Nature Communications 8, 1 (October 2017): 1079 © 2017 The Authors https://orcid.org/0000-0003-1533-6730 https://orcid.org/0000-0002-2988-0537 https://orcid.org/0000-0002-4866-1145 https://orcid.org/0000-0002-9703-1780 http://dx.doi.org/10.1038/S41467-017-01052-Y Nature Communications Creative Commons Attribution 4.0 International License http://creativecommons.org/licenses/by/4.0/ application/pdf Nature Publishing Group Nature
spellingShingle Feng, Yu-Xiong
Reinhardt, Ferenc
Jin, Dexter X.
Sokol, Ethan Samuel
Miller, Daniel Handel
Gupta, Piyush
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
title Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
title_full Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
title_fullStr Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
title_full_unstemmed Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
title_short Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
title_sort cancer specific perk signaling drives invasion and metastasis through creb3l1
url http://hdl.handle.net/1721.1/114663
https://orcid.org/0000-0003-1533-6730
https://orcid.org/0000-0002-2988-0537
https://orcid.org/0000-0002-4866-1145
https://orcid.org/0000-0002-9703-1780
work_keys_str_mv AT fengyuxiong cancerspecificperksignalingdrivesinvasionandmetastasisthroughcreb3l1
AT reinhardtferenc cancerspecificperksignalingdrivesinvasionandmetastasisthroughcreb3l1
AT jindexterx cancerspecificperksignalingdrivesinvasionandmetastasisthroughcreb3l1
AT sokolethansamuel cancerspecificperksignalingdrivesinvasionandmetastasisthroughcreb3l1
AT millerdanielhandel cancerspecificperksignalingdrivesinvasionandmetastasisthroughcreb3l1
AT guptapiyush cancerspecificperksignalingdrivesinvasionandmetastasisthroughcreb3l1